Eurofins Successfully Completes Tender Offer for €400M Hybrid Bond

Eurofins Scientific, a major player in bioanalytical testing, announced the successful completion of its tender offer for its €400 million hybrid bond. The bond, carrying an interest rate of 3.250%, was initially issued in November 2017 and had a first call date in November 2025.

As the tender offer expired on April 2, 2025, Eurofins received valid tenders amounting to €194 million. The company has accepted all valid tenders, resulting in a remaining outstanding amount of €206 million. The settlement for the purchase is scheduled for April 7, 2025.

This strategic move is part of Eurofins' refinancing efforts, following its recent issuance of a new hybrid bond maturing in 2032. Eurofins continues to manage its financial commitments while maintaining its leadership in the bioanalytical field.